DIFFUSE PLEURAL MESOTHELIOMA
Clinical trials for DIFFUSE PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for DIFFUSE PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets Hard-to-Treat cancers with genetic flaw
Disease control Recruiting nowThis early-phase trial is testing an experimental drug called BMS-986504 alongside standard cancer treatments in 60 people with advanced cancers that have lost a gene called MTAP. The cancers include mesothelioma, stomach/esophageal cancer, and bladder cancer. The main goal is to…
Matched conditions: DIFFUSE PLEURAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Promising drug targets tough mesothelioma in early trial
Disease control Recruiting nowThis study tests a drug called sacituzumab govitecan in 33 adults with mesothelioma that has come back or spread. Participants receive the drug until their disease worsens or side effects become too severe. The main goal is to see if the drug can shrink tumors and help control th…
Matched conditions: DIFFUSE PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC